Literature DB >> 11025375

Incidence, mortality and long-term survival from prostate cancer in Umbria, Italy, 1978-1994.

F La Rosa1, F Stracci, A M Petrinelli, P Casucci, V Mastrandrea.   

Abstract

OBJECTIVES AND METHODS: Incidence, mortality and long-term survival from prostate cancer were examined in the Umbria region of Italy, for the period 1978-1994. Incidence rates were derived from an ad hoc survey carried out over the period 1978-1982 and from 1994 cancer registry records. The mortality over the period derived from data of the official publications and the survival rates, at 15 years, were calculated starting from the ad hoc survey incident cases.
RESULTS: In the Umbria region, over the period 1978-1994, crude incidence rates from prostate cancer increased from 31.2 to 81. 9 per 100,000 and mortality rates from 22.7 to 31.9 per 100,000. The rates were from 30.5 to 61.2 for age-adjusted incidence while standardized mortality remained constant (from 22.6 to 22.7 per 100, 000). Survival in Umbria, compared with rates from other European Cancer Registries, is low both at 5- and 10-year follow-up.
CONCLUSION: The great incidence increase observed over the study period could depend on a lesser completeness achieved by the 1978-1982 ad hoc survey with respect to the 1994 cancer registry data and/or from the screening campaign carried out in a large part of the region in 1994. Different elements support these hypotheses. However the above hypotheses can be verified over the next years when further incidence and survival data from the cancer registry will be available.

Entities:  

Mesh:

Year:  2000        PMID: 11025375     DOI: 10.1159/000020313

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  1 in total

1.  Cancer mortality trends in the Umbria region of Italy 1978-2004: a joinpoint regression analysis.

Authors:  Fabrizio Stracci; Antonio Canosa; Liliana Minelli; Anna Maria Petrinelli; Tiziana Cassetti; Carlo Romagnoli; Francesco La Rosa
Journal:  BMC Cancer       Date:  2007-01-16       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.